is ozempic a glp 1 agonists GLP-1 pose emerging challenge for PET-CT imaging, study finds GLP-1 Receptor Agonists: A Game-Changer

Only 2.0% of placebo participants achieved 15% weight loss

Policymakers are increasingly recognizing these potential savings and are exploring the idea of expanding coverage for these drugs under programs like Medicare, which could reduce long-term healthcare spending (Goldman & Ward, 2024)

Some of the side effects may not be a result of the drug but the weight loss itself Levy says hair loss is incredibly common in people who lose a lot of weight or they could be due to an underlying disease

Motus is a compelling oral, evidencebacked option for people who prefer pills to injections and value a researchdriven supplement approach